Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ann-Charlotte Aveberger"'
Autor:
Karin Palmblad, Erik Sundberg, Huan Yang, Ann-Charlotte Aveberger, Ulf Andersson, R. Kokkola, Kevin J. Tracey, Jian Li, H. Erlandsson Harris
Publikováno v:
Arthritis & Rheumatism. 48:2052-2058
Objective Extracellular high mobility group box chromosomal protein 1 (HMGB-1) is a recently identified, endogenous, potent tumor necrosis factor– and interleukin-1 (IL-1)–inducing protein detectable in inflamed synovia in both human and experime
Autor:
Lena Klevenvall, Ulf Andersson, Ann Charlotte Aveberger, Hulda Sigridur Hreggvidsdottir, Helena Erlandsson Harris, Anna M. Lundberg
The nuclear protein high mobility group box protein 1 (HMGB1) promotes inflammation upon extracellular release. HMGB1 induces proinflammatory cytokine production in macrophages via Toll-like receptor (TLR)-4 signaling in a redox-dependent fashion. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0dccfeae530a71603a4e522c371fcf8
https://europepmc.org/articles/PMC3320135/
https://europepmc.org/articles/PMC3320135/
Autor:
Helena Erlandsson Harris, Hulda Sigridur Hreggvidsdottir, Ann-Charlotte Aveberger, Lars Ottosson, Lena Klevenvall, Hanna Schierbeck, Ulf Andersson, Heidi Wähämaa, Karin Palmblad, Therese Östberg
Publikováno v:
Journal of leukocyte biology. 86(3)
A prototypic mechanism for enhancement of inflammation by an endogenous molecule is described. The nuclear protein HMGB1 has previously been demonstrated to act as an alarmin and to promote inflammation upon extracellular release, yet its mode of act
Autor:
Weiwen Jiang, Ann-Charlotte Aveberger, Cecilia K Zetterström, Hanna Schierbeck, Heidi Wähämaa, David S. Pisetsky, Helena Erlandsson Harris, Therese Östberg, Michael T. Lotze, Ulf Andersson
Publikováno v:
Journal of leukocyte biology. 83(1)
Gold compounds such as gold sodium thiomalate (GST) can reduce the symptoms of rheumatoid arthritis (RA), although their mechanism of action is not well defined. As the proinflammatory mediator high mobility group box chromosomal protein 1 (HMGB1) ma
Autor:
Erik Sundberg, Chris Pruunsild, Rille Pullerits, Karin Palmblad, Dirk Holzinger, Ann-Charlotte Aveberger, Helena Erlandsson Harris, Marie Fischer, Hanna Schierbeck
Publikováno v:
Annals of the Rheumatic Diseases. 71:A10.2-A11
Backgroundand objectives The endogenous danger signal High Mobility Group Box protein 1 (HMGB1) promotes inflammation. HMGB1 has been implicated as a mediator of RA while there are no reports describing its presence in JIA patient samples. HMGB1 is a
Autor:
Ann-Charlotte Aveberger, Lena Klevenvall, Ulf Andersson, Helena Erlandsson Harris, Hulda Sigridur Hreggvidsdottir, Anna M. Lundberg
Publikováno v:
Annals of the Rheumatic Diseases. 71:A80.1-A80
Background and objectives The pro-inflammatory protein HMGB1 is a pathogenic mediator in several inflammatory diseases as demonstrated by beneficial effects of HMGB1-blocking therapy in experimental models including arthritis. High levels of extracel
Autor:
Ulf Andersson, Therese Östberg, Lena Klevenvall, Hanna Schierbeck, Heidi Wähämaa, H Sigridur Hreggvidsdottir, Ann-Charlotte Aveberger, H. Erlandsson Harris
Publikováno v:
Annals of the Rheumatic Diseases. 69:A38-A38
The proinflammatory protein HMGB1 was recently identified as a mediator of rheumatoid arthritis (RA) and of other inflammatory diseases. This is demonstrated by extracellular HMGB1 expression both in experimental models of arthritis and in synovial b
Autor:
Erik Sundberg, Karin Palmblad, Ann-Charlotte Aveberger, Helena Erlandsson Harris, Riikka Söderling, Margarita Diez, Ulf Andersson
Publikováno v:
Arthritis Research & Therapy
High-mobility group chromosomal box protein 1 (HMGB1) is a structural nuclear protein that promotes inflammation when present extracellularly. Aberrant, extracellular HMGB1 expression has been demonstrated in human and experimental synovitis. The aim
Autor:
Ann-Charlotte Aveberger, Helena Erlandsson-Harris, Karin Palmblad, Huan Yang, Ona Bloom, Alfred Janson, Minghuang Zhang, Ulf Andersson, Haichao Wang, R. Kokkola, Kevin J. Tracey
Publikováno v:
Karolinska Institutet
The Journal of Experimental Medicine
The Journal of Experimental Medicine
Lipopolysaccharide (LPS) is lethal to animals because it activates cytokine release, causing septic shock and tissue injury. Early proinflammatory cytokines (e.g., tumor necrosis factor [TNF] and interleukin [IL]-1) released within the first few hour
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a148f2a034e1b6fbbe692d1746e16a2
http://www.ncbi.nlm.nih.gov/pubmed/10952726
http://www.ncbi.nlm.nih.gov/pubmed/10952726